Background illustration for clinical trials search

Paid Clinical Trials High Point

Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Oxygen Toxicity: Mechanisms in Humans

for
Oxygen Toxicity, Hypercapnia, Seizures
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 45

Code: NCT05761756

Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, Nashville TN, New York NY,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting
Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting
Featured

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Chapel Hill NC, Philadelphia PA, Cleveland OH,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT06332534

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia (CLL)
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT04895436

Phase2, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Winston-Salem NC, Charlotte NC, Fairfax VA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Salisbury NC, Salem VA, Greenville NC, Myrtle Beach SC,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

Cochlear Implants in Young Children With SSD

for
Single Sided Deafness, Unilateral Deafness,
Location: Durham NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 0 - 5

Code: NCT05775367

Recruiting

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

for
HIV Prevention, HIV Pre-exposure Prophylaxis,
Location: Durham NC
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT07218211

Recruiting

Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

for
COPD (Chronic Obstructive Pulmonary Disease), Hypoxemia
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 40+

Code: NCT07037836

Phase2, Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

for
Indolent Systemic Mastocytosis,
Location: Durham NC, Atlanta GA, Cincinnati OH, Birmingham AL,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT04910685

Phase2, Phase3, Recruiting

Using PrEP, Doing It for Ourselves

for
HIV Prevention, PrEP
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18+

Code: NCT06638892

Recruiting

A Study of Buntanetap in Participants With PD

for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Durham NC, Charlottesville VA, Charleston SC,
Sponsor: Annovis Bio Inc.

Sex: All

Age: 40 - 70+

Code: NCT07284784

Phase2, Phase3, Recruiting

Collecting Outcomes and Managing Pain After Surgery

for
Surgery
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 70+

Code: NCT03834818

Recruiting

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

for
Congenital Antithrombin Deficiency
Location: Durham NC, Washington D.C. DC, New York NY, Peoria IL,
Sponsor: Octapharma

Sex: All

Age: 12 - 70+

Code: NCT04918173

Phase3, Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for
Non Hodgkin Lymphoma,
Location: Durham NC, New Haven CT, Chicago IL, Boston MA,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06116110

Recruiting

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

for
Hematologic Malignancy
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06532773

Recruiting

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

for
Focal Onset Seizures
Location: Durham NC, Bethesda MD, Columbus OH, Nashville TN,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05716100

Phase3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Durham NC, Charlotte NC, Charlottesville VA, Augusta GA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting